Molecular mechanisms in the progression of pancreatic neuroendocrine tumors
Nancy Joseph, MD, PhD
Active Projects
Neoantigen-reactive T Cells for personalized treatment of panNETs
Mauro Cives, MD
New strategies to improve drug development for carcinoid tumors
Emily Bergsland, MD
Novel Therapeutic Vulnerabilities in Cervical Neuroendocrine Carcinoma
Haider S. Mahdi, MD
Optimizing chelator compositions for alpha particle-based PRRT in neuroendocrine tumors
Dongyoul Lee, PhD
PANNET Modeling, Mechanisms, and Experimental Treatment
James Bibb, PhD
PRESCIENT – PET ResponSe CrItEria for Neuroendocrine Tumors
Lisa Bodei, MD, PhD
Radiosensitizing NETs: a two-pronged approach using ERa and Pin1 inhibition
Xavier M. Keutgen, MD
Reconciling lung carcinoids histopathological and molecular classifications
Matthieu Foll, PhD
Reconstructing the evolutionary history of neuroendocrine tumor subtypes
Nicolas Alcala, PhD